Analytical Solutions for the Combination Medical Device Development Process

Overview


RSSL-wWP-Pharma-2015-Analytical-Solutions-for-the-Combination-Medical-Device-Development-Process.png

Billions of patients worldwide benefit from a diverse range of medical devices. The global medical device market in 2011 was approximately $300 billion and is predicted to grow by 4% per year to reach over $400 billion by 2018. Specifically, the European medical device market is estimated to make up 30% of global sales (i.e. $100 billion) and is second only to the US which makes up 40% of the market.

A medical device is an implant, implement, instrument, apparatus, in vitro reagent or other similar article that can diagnose, prevent, monitor, treat and alleviate disease.

This content is provided by RSSL, and any views and opinions expressed do not necessarily reflect those of Outsourcing-Pharma.com

Download Now


Latest Content

Extractables and leachables analysis of pharmaceutical products

Extractables and leachables analysis of pharmaceutical products

Paid for and content provided by RSSL

A crucial undertaking when releasing pharmaceutical products for the market, is to determine the purity of the final product, necessitating the need to determine its impurity profile. Traditionally, this was concerned only with those impurities arising...

Related Resources

Elemental Impurities Regulations View from a CRO

Elemental Impurities Regulations View from a CRO

Content provided by RSSL

White Paper

Regulatory control of elemental impurities in pharmaceutical products has long been discussed, with both the European Pharmacopeia (EP) and the United States Pharmacopeia (USP) having planned on...

Supplier Info Centre

RSSL-SIC-Pharma-2016.png

For more product information visit RSSL.